Britain approves world's first gene therapy Casgevy for sick

The UK drug regulator says it approved Casgevy for patients with sickle cell disease and thalassemia who are 12 years old and over

Related Keywords

India , United Kingdom , Britain , , Healthcare Regulatory Agency On , Vertex Pharmaceuticals , Drug Administration , Vertex Pharmaceuticals Europe Ltd , Healthcare Regulatory Agency , Middle Eastern , Sickle Cell , Thalassemia , Uk , Gene Therapy , Crispr Therapeutics ,